Andilab, Meryll Faith .

HRN: 28-63-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/13/2026
03/14/2026
IV
500mg
Q8
Cs
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines